Alpha DNA Investment Management’s AGCO AGCO Stock Holding History

Alpha DNA Investment Management’s Portfolio AGCO Stock Details AGCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,511	Closed	-$305K	–	195
2023 Q4	$305K	Sell	2,511 -4,206	-63%	-$492K	0.12%	163
2023 Q3	$794K	Sell	6,717 -864	-11%	-$110K	0.33%	63
2023 Q2	$996K	Sell	7,581 -391	-5%	-$48.5K	0.33%	71
2023 Q1	$1.08M	Buy	+7,972	New	+$1.08M	0.32%	85
2021 Q1	–	Sell	-54	Closed	-$5K	–	676
2020 Q4	$5K	Buy	+54	New	+$4.8K	0.01%	356

Other funds holding AGCO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirova US Boston, Massachusetts $8.81B AUM 21.38% 1-Year Est. Return

Alpha DNA Investment Management's AGCO Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of AGCO (AGCO) in Q1 2024, closing a stake of 2,511 shares — an estimated $305K sold.

Alpha DNA Investment Management first reported a position in AGCO in Q4 2020 and held it in 5 quarters. The position peaked at $1.08M in Q1 2023. 518 funds tracked by Wall St. Rank hold AGCO as of Q1 2024.

Alpha DNA Investment Management reported no remaining AGCO position as of Q1 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 2,511 AGCO shares in Q1 2024, an estimated $305K.
Alpha DNA Investment Management first reported a position in AGCO in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's AGCO position peaked at $1.08M in Q1 2023.
518 funds tracked by Wall St. Rank held AGCO as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.